Pancreatic Cancer Research

ResearcherThe University of Texas at AustinActive in the last 2 years

Curtis Jackson Wray

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4425-4566; OpenAlex author ID A5012684884. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 8

  1. Combination Immunotherapy Enhances Serial Radiofrequency Ablation Induced Systemic Antitumor Immunity in Pancreatic Cancer Co-author DOI 10.64898/2026.04.05.713683↗
  2. EUS-guided radiofrequency ablation for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.gie.2024.04.2926↗
  3. Endoscopic innovations in diagnosis and management of pancreatic cancer: a narrative review and future directions. Co-author DOI 10.1177/17562848241297434↗
  4. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-22-2553↗
  5. Radiofrequency Ablation Remodels the Tumor Microenvironment and Promotes Neutrophil-Mediated Abscopal Immunomodulation in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-22-0379↗
  6. Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ducta… Co-author DOI 10.3389/fonc.2022.995027↗
  7. Pancreatic cancer ductal cell of origin drives CD73-dependent generation of immunosuppressive adenosine Co-author DOI 10.1101/2021.11.29.470415↗
  8. A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival. Co-author DOI 10.1245/s10434-012-2361-z↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nirav C Thosani · 7 shared papers, 2021–2026 · strength 1.30
  2. Jennifer M. Bailey · 6 shared papers, 2021–2026 · strength 0.99
  3. Erika Yanil Faraoni · 5 shared papers, 2021–2024 · strength 0.76
  4. Lincoln N. Strickland · 4 shared papers, 2022–2026 · strength 0.68
  5. Putao Cen · 3 shared papers, 2023–2026 · strength 0.61
  6. Prateek Suresh Harne · 1 shared paper, 2024 · strength 0.31
  7. Urvinder Kaur Sardarni · 1 shared paper, 2026 · strength 0.23
  8. Khadija Shahab Turabi · 1 shared paper, 2026 · strength 0.23
  9. Jesse L. Cox · 1 shared paper, 2026 · strength 0.23
  10. MacKenzie V. Demmel · 1 shared paper, 2026 · strength 0.23
  11. Sunil R. Hingorani · 1 shared paper, 2026 · strength 0.23
  12. Dafna Bar‐Sagi · 2 shared papers, 2021–2023 · strength 0.22
  13. Powel H. Brown · 2 shared papers, 2021–2023 · strength 0.22
  14. Kanchan Singh · 2 shared papers, 2021–2023 · strength 0.22
  15. Vidhi Chandra · 2 shared papers, 2021–2023 · strength 0.22
  16. Altaf Mohammed · 2 shared papers, 2021–2023 · strength 0.22
  17. Florencia M. McAllister · 2 shared papers, 2021–2023 · strength 0.22
  18. George Van Buren · 2 shared papers, 2021–2023 · strength 0.22
  19. Le Li · 1 shared paper, 2023 · strength 0.13
  20. Tien C. Ko · 1 shared paper, 2012 · strength 0.04
  21. Lillian S. Kao · 1 shared paper, 2012 · strength 0.04
  22. Eric Jay Silberfein · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.